Cocaine use may modify HIV/ART-associated myocardial steatosis and hepatic steatosis

Shenghan Lai, Gary Gerstenblith, Richard D. Moore, David D. Celentano, David A. Bluemke, Glenn Treisman, Chia Ying Liu, Ji Li, Shaoguang Chen, Thomas Kickler, Hong Lai

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Background It has been recognized that myocardial and hepatic steatosis may be more prevalent in HIV-infected individuals on antiretroviral therapy (ART); however, factors associated with these conditions have not been thoroughly investigated. The goals of this study were (1) to identify the risk factors for myocardial and hepatic steatosis in HIV-infected African Americans (AAs) and explore whether ART use is independently associated with myocardial and hepatic steatosis, and (2) to examine whether and how cocaine use influences any associations of ART use with myocardial and hepatic steatosis. Methods Between June 2010 and December 2013, 220 HIV-infected AAs in Baltimore, Maryland, were enrolled in a study investigating HIV/ART-associated myocardial and hepatic damage. Proton magnetic resonance spectroscopy was performed to quantify myocardial and hepatic triglyceride contents. Sociodemographic, medical and laboratory data were also obtained. Robust regression model was employed to perform primary statistical analysis. Results Robust regression analyses showed that (1) duration of protease inhibitor (PI) use was independently associated with myocardial and hepatic triglyceride contents, (2) duration of PI use was independently associated with myocardial triglyceride in cocaine users (p = 0.025), but not in cocaine never-users (p = 0.84), and (3) duration of PI use was independently associated with hepatic triglyceride in cocaine users, but not in cocaine never-users (p = 0.52). Conclusions Cocaine use may trigger/exacerbate the toxicity of PI in ART-associated myocardial and hepatic steatosis, suggesting that cocaine abstinence/reduced use may retard these ART-associated comorbidities. Clinical trials should be conducted to examine whether reduced cocaine use improves HIV/AIDS-associated myocardial and hepatic steatosis.

Original languageEnglish (US)
Pages (from-to)84-92
Number of pages9
JournalDrug and alcohol dependence
Volume177
DOIs
StatePublished - Aug 1 2017

Keywords

  • African Americans
  • Antiretroviral therapy
  • Cocaine use
  • HIV infection
  • Hepatic triglyceride content
  • Myocardial triglyceride content

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Cocaine use may modify HIV/ART-associated myocardial steatosis and hepatic steatosis'. Together they form a unique fingerprint.

Cite this